Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH?

被引:96
作者
Gambino, Roberto
Cassader, Maurizio
Pagano, Gianfranco
Durazzo, Marilena
Musso, Giovanni
机构
[1] Gradenigo Hosp, Dept Emergency, I-10126 Turin, Italy
[2] Univ Turin, Dept Internal Med, Turin, Italy
关键词
D O I
10.1002/hep.21631
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is emerging as an independent cardiovascular risk factor, but mechanism(s) linking fatty liver to atherosclerosis are unknown. Microsomal triglyceride transfer protein (MTP) -493 G/T polymorphism modulates circulating lipid and lipoprotein levels in different subsets and has been linked to NAYLD. The impact of MTP -493 G/T polymorphism, adipokines, and diet on postprandial lipoprotein profile and liver disease was assessed in nonalcoholic steatohepatitis (NASH). Plasma lipids, triglyceride-rich lipoprotein subfractions, high-density lipoprotein-C (HDL-C), and oxidized low-density lipoprotein (LDL) after an oral fat load were cross-sectionally correlated to MTP -493 G/T polymorphism, dietary habits, adipokines, and liver histology in 29 nonobese nondiabetic patients with NASH and 27 healthy controls. The severity of liver histology, the magnitude of triglycerides (Tg), free fatty acid (FFA), and LDL-conjugated diene responses, and the fall in HDL-C and apoA1 were significantly higher in NASH G/G (66% of patients) than in the other genotypes, despite similar adipokine profile and degree of insulin resistance. Postprandial. large intestinal very-low-density lipoprotein (VLDL) subfraction A increases independently predicted Tg (beta = 0.48; P =.008), FFA (beta = 0.47; P = 0.010), HDL-C (beta = 0.42; P = 0.009), and LDL-conjugated diene (beta = 0.52; P = 0.002) responses. VLDL A apoB48 response was independently associated with liver steatosis (OR: 2.4; CI 1.7-9.6; P = 0.031). Postprandial. LDL-conjugated diene response predicted severe necro-inflammation (OR: 3.3; CI 1.4-9.7; P = 0.016) and fibrosis (OR: 2.8; CI 1.0-8,5; P = 0.030); postprandial apoA1 fall predicts severe fibrosis (OR: 2.1; CI: 1.5-6.1; P = 0.015). Conclusion: MTP -493 G/T polymorphism may impact NASH by modulating postprandial lipernia and lipoprotein metabolism; homozygous GG carriers have a more atherogenic postprandial. lipid profile than the other genotypes, independently of adipokines and insulin resistance.
引用
收藏
页码:1097 / 1107
页数:11
相关论文
共 37 条
[1]   Overproduction of large VLDL particles is driven by increased liver fat content in man [J].
Adiels, M ;
Taskinen, MR ;
Packard, C ;
Caslake, MJ ;
Soro-Paavonen, A ;
Westerbacka, J ;
Vehkavaara, S ;
Hakkinen, A ;
Olofsson, SO ;
Yki-Jarvinen, H ;
Borén, J .
DIABETOLOGIA, 2006, 49 (04) :755-765
[2]   Nonalcoholic steatohepatitis: Definition and pathology [J].
Brunt, EM .
SEMINARS IN LIVER DISEASE, 2001, 21 (01) :3-16
[3]  
Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI200523621, 10.1172/JCI23621]
[4]   Nonalcoholic fatty liver disease: From steatosis to cirrhosis [J].
Farrell, GC ;
Larter, CZ .
HEPATOLOGY, 2006, 43 (02) :S99-S112
[5]   Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition [J].
Grundy, SM ;
Brewer, HB ;
Cleeman, JI ;
Smith, SC ;
Lenfant, C .
CIRCULATION, 2004, 109 (03) :433-438
[6]  
Ikura Y, 2005, HEPATOLOGY, V42, p620A
[7]   A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels [J].
Karpe, F ;
Lundahl, B ;
Ehrenborg, E ;
Eriksson, P ;
Hamsten, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) :756-761
[8]   Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis [J].
Koruk, M ;
Savas, C ;
Yilmaz, Ö ;
Taysi, S ;
Karakok, M ;
Gündogdu, C ;
Yilmaz, A .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (02) :177-182
[9]  
KULLER LH, 2006, IN PRESS ATHEROSCLER
[10]  
Lu LG, 1999, CHINESE MED J-PEKING, V112, P325